Brown adipose tissue (BAT) burns chemical energy as heat via uncoupling protein 1 (UCP1) — distinct from white adipose tissue (WAT) energy storage. UCP1 sits in the mitochondrial inner membrane and dissipates the proton gradient, decoupling fuel oxidation from ATP synthesis → heat. Mechanism: cold exposure → sympathetic activation → norepinephrine → β3-adrenergic receptor on brown adipocyte → Gs → cAMP → PKA → HSL → lipolysis → free fatty acids → activate UCP1 (FFAs are required allosteric activators). Result: thermogenesis 100–300 W/kg BAT (vs. WAT near zero). BAT vs beige (brite) adipose: classical BAT is interscapular + supraclavicular (high UCP1, multilocular lipid droplets, dense mitochondria). Beige adipocytes appear in WAT depots after cold / exercise / β3 stimulation ("browning"). PRDM16 + PGC-1α are master transcriptional regulators. Human relevance: adult humans have functional BAT (FDG-PET-detectable) in supraclavicular + perirenal depots — activated by cold (~10× metabolic rate in BAT alone); inversely correlated with BMI, age, glucose intolerance. Therapeutic landscape: mirabegron — β3-AR agonist (FDA-approved for overactive bladder; off-label BAT activation trials show modest metabolic benefit); GLP-1 agonists + tirzepatide → indirect BAT effects via weight loss + central mechanisms; thyroid hormone (T3) → UCP1 expression; capsaicin / TRPV1 → cold-mimetic activation; cold exposure + exercise → BAT recruitment + WAT browning. Cross-links: adrenergic receptor signaling (β3-AR), catecholamine synthesis (NE from sympathetic), hpt axis (T3 enhancement), insulin glucose homeostasis (BAT improves glycemia).
Organ Systems
endocrine
cardiovascular
integumentary
Pathway Steps
cold exposure + sympathetic activation → norepinephrine release onto BAT — via sympathetic innervation density high in BAT; small cold = large NE release. Brown-fat thermogenesis is switched on by cold: hypothalamic sensing drives sympathetic nerves to release norepinephrine directly onto brown adipocytes. This neural (not hormonal) control couples BAT activity tightly to acute cold exposure — the basis for the cold-induced BAT activity seen on human PET imaging.
norepinephrine + β3-AR (BAT) → Gs → cAMP → PKA activation — via β3-AR is the BAT-preferring β-receptor subtype. Norepinephrine acts mainly through the β3-adrenergic receptor, which couples to Gs to raise cAMP and activate PKA. The β3-AR predominance is why selective β3 agonists (e.g. mirabegron) can activate human BAT — an actively pursued anti-obesity and metabolic strategy.
PKA active → HSL activation → lipolysis → free fatty acids — via cytoplasmic FFAs are required allosteric activators of UCP1. PKA phosphorylates hormone-sensitive lipase (and perilipin), triggering lipolysis of stored triglyceride to free fatty acids. In brown fat these fatty acids are not just fuel — they are the direct activators of the thermogenic effector, coupling lipid mobilization to heat production.
free fatty acids + UCP1 (mitochondrial inner membrane) → proton gradient dissipation → heat — via short-circuits oxidative phosphorylation; chemical → thermal energy. The defining step: free fatty acids activate UCP1 (thermogenin) in the inner mitochondrial membrane, letting protons leak back into the matrix and bypass ATP synthase. This uncouples oxidation from ATP production, so the proton-gradient energy is dissipated as heat — the molecular heart of non-shivering thermogenesis.
sustained β3 + cold + exercise → WAT browning (beige adipocyte induction) — via PRDM16 + PGC-1α → UCP1-expressing beige cells emerge in WAT depots. With sustained β3-adrenergic drive (chronic cold or exercise), white adipose depots recruit UCP1-positive “beige/brite” adipocytes — browning. Because beige fat expands thermogenic capacity in humans (who have limited classical BAT), inducing browning is a major target for raising energy expenditure.
thyroid hormone (T3) → UCP1 transcriptional enhancement — via TR-β nuclear receptor on UCP1 promoter; cross-link hpt_axis. Thyroid hormone amplifies the program: locally generated T3 (via BAT-enriched deiodinase D2) enhances UCP1 transcription and sensitizes the tissue to adrenergic stimulation. This is why thyroid status strongly influences basal metabolic rate and cold tolerance, integrating endocrine with neural control.
Known Modulators
mirabegron (activator) — β3-AR (FDA-approved for OAB; off-label BAT activation trials)
semaglutide (activator) — indirect BAT activation via weight loss + central mechanisms
tirzepatide (activator) — GLP-1/GIP — indirect BAT effects